SciSparc Ltd. Stock News

Cannabinoid biotech specialist SciSparc (NASDAQ: SPRC ) is enjoying a much-needed boost on Wednesday thanks to a key investment deal. This morning, management announced an equity purchase agreement wi

Shares of drug discovery specialist SciSparc (NASDAQ: SPRC ) are popping sharply today on encouraging clinical study results. Specifically, the company's joint venture (JV) project MitoCareX Bio achie

SciSparc Ltd.'s stock SPRC was up 74% on Friday, two days after the clinical-stage biopharmaceutical company said it agreed to merge with an unnamed company in Israel.

SciSparc (NASDAQ: SPRC ) stock is rising higher on Wednesday as investors react to the company signing a letter of intent for a merger. That merger would be with a leading vehicle importer company in

SciSparc (NASDAQ: SPRC ) stock is taking off on Wednesday after the company released results from a Phase IIa trial of SCI-110 as an Alzheimer's Disease agitation treatment. The clinical trial covered

SciSparc (NASDAQ: SPRC ) stock is taking off on Tuesday after the pharmaceutical company posted positive patent news. The big news here is the company's patent for ‘Combination of Opioids and N-Acyl

SciSparc (NASDAQ: SPRC ) stock is rising higher on Tuesday after the pharmaceutical company regained listing compliance. SciSparc notes that the Nasdaq Exchange has closed a complaint against the com

Following the reverse share split, the Company will have approximately 521,090 Ordinary Shares issued and outstanding TEL AVIV, Israel -- September 27, 2023 -- InvestorsHub NewsWire -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announces today that its previously announced reverse share split of its...

Some of the most promising penny stocks are up-and-coming and just just getting started. The world of penny stocks is all about speculating which young firms have the potential to become the next big

If there's one thing we know now it's that catalysts play a significant role in trading penny stocks. This is where things like sympathy sentiment can play a much larger role.

SciSparc and Clearmind Reveal Three Unique Combinations of Future Psychedelic-Based Compounds Clearmind Medicine submitted patent applications to protect the novel compounds Tel Aviv, Israel, Feb. 22, 2023 -- InvestorsHub NewsWire -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced today that as part of its o...

How fundamental analysis helps investing in penny stocks The post The Role of Fundamental Analysis in Penny Stock Investing appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt

SciSparc (NASDAQ: SPRC ) stock is taking off on Friday as investors react to an update on its drug development joint venture. MitoCareX Bio is the joint venture behind today's rise.

Penny stocks to watch with news that are turning heads in the stock market this week. The post 5 Penny Stocks To Watch After Big News This Week appeared first on Penny Stocks to Buy, Picks, News and I

Check these recommendations for buying penny stocks The post Buying Penny Stocks? 3 Analyst Recommendations to Use appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.